The role of ghrelin in weight gain and growth in epileptic children using valproate

Journal of Child Neurology

Volumn 22, Issue 12, 2007, Pages 1384-1388

  Gungor, Serdal ^a   Yücel, Gül ^a   Akinci, Ayşehan ^a   Tabel, Yilmaz ^a   Ozerol, Ibrahim Halil ^a   Yologlu, Saim ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Body weight; Ghrelin; Valproate

Indexed keywords

C PEPTIDE; GHRELIN; GLUCOSE; INSULIN; LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; VALPROIC ACID;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD GROWTH; CHILDHOOD DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; EPILEPSY; FEMALE; GLUCOSE BLOOD LEVEL; GROWTH RATE; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; MALE; MONOTHERAPY; PREPUBERTY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIDE EFFECT; TREATMENT DURATION; WEIGHT GAIN;

ADOLESCENT; ANTICONVULSANTS; BLOOD GLUCOSE; BODY HEIGHT; BODY MASS INDEX; BODY WEIGHT; C-PEPTIDE; CHILD; CHILD, PRESCHOOL; EPILEPSY; FEMALE; GHRELIN; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; PUBERTY; VALPROIC ACID; WEIGHT GAIN;

EID: 36749087648     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/0883073807307096     Document Type: Article

References (24)

1. Bebin M. Pediatric partial and generalized seizures. J Child Neurol. 2002;17:65-69.
2. Biton V., Mirza W., Montouris G., et al. Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology. 2001;56:172-177.
3. Jallon P., Picard F. Body weight gain and anticonvulsants. Drug Saf. 2001;24:969-978.
4. Corman CL, Leung NM, Guberman AH Weight gain in epileptic patients during treatment with valproic acid: A retrospective study. Can J Neurol Sci. 1997;24:240-244.
5. Gale SM, Castracane D., Mantzoros CS Ghrelin and the regulation of energy homeostasis. Clin Lab Int. 2003;27:12-14.
6. Greco R., Latini G., Chiarelli F., et al. Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acid. Neurology. 2005;65:1808-1809.
7. Sun Y., Ahmed S., Smith RG Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol. 2003;23:7973-7981.
8. Asakawa A., Inui A., Kaga T., et al. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice. Gut. 2003;52:947-952.
9. Cummings DE, Purnel JQ, Weigle DS, et al. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714-1719.
10. Bagnasco M., Dube MG, Katz A., et al. Leptin expression in hypothalamic PVN reverses dietary obesity and hyperinsulinemia but stimulates ghrelin. Obes Res. 2003;11:1463-1470.
11. Lee PA Disorders of puberty. In: Lifshitz F, ed. Pediatric Endocrinology. 3rd ed. New York: Marcel Dekker; 1996: 175-195.
12. Mathews DR, Hasker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentration in man. Diabetelogia. 1985;28:412-419.
13. Anderson G. Children versus adults: Pharmacokinetic and adverse-effect differences. Epilepsia. 2002;43:53-59.
14. Coulter DL Carnitine deficiency: A possible mechanism for valproate hepatotoxicity. Lancet. 1984;24:689.
15. Verrotti A., Basciani F., Morresi S., et al. Serum leptin changes in epileptic patients who gain weight after therapy with valproic acid. Neurology. 1999;53:230-232.
16. Nakazato M., Murakarni N., Date Y., et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194-198.
17. Yildiz BO, Suchard MA, Wong ML, et al. Alterations in the dynamics of circulating ghrelin, adiponectin, and leptin in human obesity. Proc Natl Acad Sci USA. 2004;101:10434-10439.
18. Whatmore AJ, Hall CM, Jones J., et al. Ghrelin concentrations in healthy children and adolescents. Clin Endocrinol. 2003;59:649-654.
19. Wren AM, Seal LJ, Cohen MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992-5995.
20. Isojarvi JIT, Tauboll E., Pakarinen AJ, et al. Altered ovarian function and cardiovascular risk factors in valproate-treated women. Am J Med. 2001;111:290-296.
21. Pylvanen V., Knip M., Pakarinen A., et al. Serum insulin and leptin levels in valproate-associated obesity. Epilepsia. 2002;43:514-517.
22. Vainionpaa LK, Rattya J., Knip M., et al. Valproate-induced hyperandrogenism during pubertal maturation in girls with epilepsy. Ann Neurol. 1999;45:444-450.
23. Rattya J., Vainionpaa L., Lanning P., Isojarvi JIT. The effects of valproate, carbamazepine, oxcarbazepine on growth and sexual maturation in girls with epilepsy. Pediatrics. 1999;103:588-593.
24. Malik IA, English PJ, Ghatei MA, et al. The relationship of ghrelin to biochemical and anthropometric markers of adult growth hormone deficiency. Clin Endocrinol. 2004;60:137-141.